PROJECT SUMMARY
Title of the project: Sahel Malaria and Neglected Tropical Diseases (SMNTD)
Geographical coverage:
- Burkina Faso (20 districts: Nouna, Solenzo,Toma , Tougan, Banfora, Sindou, Bogande, Diapaga, Fada n'gourma, Ggayeri, Dande, Do, Orodara, Ouahigouya, Titao, Djibo, Dori, Gorom-gorom and Sebba)
- Mali (19 districts: Sikasso, Kadiolo, Koutiala, Yorosso, Tominian, Bankass, Koro, Douentza, Gourma-Rharous, Ansongo, Menaka, Tin Essako, Bougouni, Yanfolila, Kita et Kolondiéba, Yelimané, Tombouctou, Kati)
- Niger (17 districts: Say, Ilela, Filingué, Kollo, Tera, Zinder, Matameye, Mayahi, Aguie, Mirriah, Madarounfa, Guidan-Roumdji, Magaria, Boboye, Gaya, Tchin Tabaraden et Birnin Konni)
Start date: 7 October 2015 (but was official launched in Bamako, Mali on 16 July 2016)
Effectiveness date: 3 May 2016
End date: 31 December 2020
Total budget: 121 Million USD out of which 10 Million to WAHO
Project development objective: Increase access to and use of harmonized community-level services for the prevention and treatment of malaria and selected neglected tropical diseases in targeted border areas.
Components:
- C1: Improve regional collaboration for stronger results across countries
- C2: Support malaria and NTD service delivery in border areas
- C3: Strengthen institutional capacity to coordinate and monitor implementation.
Regional Coordination:
- CR1 : West African Health Organization (WAHO)
- CR2 : World Health Organization (WHO)
- CR3 : Centrale d’Achat des Médicaments Essentiels Génériques (CAMEG) Burkina Faso (Central Medical Store)
- CR4 : Other Regional institutions/Agencies
Implementing Agencies:
- CR1 : West African Health Organization (WAHO) for regional coordination
- CR2 : World Health Organization (WHO) for technical assistance to countries
- CR3 : Centrale d’Achat des Médicaments Essentiels Génériques (CAMEG) Burkina Faso (Central Medical Store) (for bulk purchases)
- CR4 : Regional research institutions
2016-2020 Strategic Plan Programs to which the project contributes:
- P1: Health Information and Research for Health;
- P2: Disease Control;
- P5 : Medicines, Vaccines and other Health Products;
- P7: Maternal, child, adolescent, youth health including the aged;
- P10 : Human Resources for Health;
- P11: Technical assistance to Member States;
- P12: Technical and financial cooperation and policy harmonization.